Rapid Alert
DRAP Alert No | No I/S/09-24-33 |
Action Date | 10th September 2024 |
Target Audience | · Pharmacists and Chemists at Distribution, Pharmacies and Medical Stores · Healthcare Professionals- Physicians, Pharmacists, and Nurses at hospitals and clinics etc. · General Public |
Problem / Issue | The Directorate of Drugs Control (DDC), Punjab has identified contamination of Ethylene Glycol in following liquid preparations. Drug Testing Laboratories (DTLs) have declared these batches of products as Substandard based on their analysis which revealed the presence of Ethylene Glycol exceeding limits. T |
Therapeutic Good(s) Affected: –
The details of the affected batches are as follows:
S# | Product Name | Composition | Batch No. | Manufactured by |
01 | Texcol EX Syrup 120ml Reg. No. 030897 | Aceylline Piperazine 45mg/5ml, Diphenhydramine HCl 8mg/5ml | 63864 | M/s. Razee Therapeutics (Pvt.) Ltd., Lahore |
02 | Speczine Syrup 120ml Reg. No. 012597 | Promethazine HCl 5mg/5ml | 609 604 YZ | M/s. Spectrum Laboratories, Lahore |
03 | Mexair Syrup 60ml Reg. No. 02665 | Terbutaline Sulphate 1.5mg/5ml | 05-23 02-22 | M/s. Siza Int., Lahore |
04 | Stazin Syrup 60ml Reg. no. 026326 | Cetrizine HCl 5mg/5ml | GI 83 | M/s. Munawar Pharma (Pvt.) Ltd., Lahore |
05 | Zevirol Expectorant syrup 120ml Reg. No. 009378 | Dipenhydramine HCl 13.5mg, Ammonium Chloride 131.5mg, sodium citrate 55mg, Menthol 1mg | 4031 | P.D.H. Laboratories Lahore |
06 | Stazin Syrup 60ml Reg. No. 026326 | Cetrizine HCl 5mg/5ml | GI83 | M/s. Munawar Pharma Lahore |
07 | Zevirol Expectorant syrup 120ml Reg. No. 009.78 | Diphenhydramine 13.5mg, Ammonium Choride 131.5mg | 4031 | M/s. P.D.H. Pharmaceuticals Lahore |
08 | Aphylin Expectorant Syrup Reg. No. 026635 | Aminophylline 32mg/5ml, Diphenhydramine 8mg/5ml, Amonium Chloride 30mg/5ml | 24C090 | M/s. Obsons Pharmaceuticals Lahore |
09 | Resfyl Syrup Reg. No. 057214 | Acefylline Piperzine 45mg/5ml, Diphenhydramine 8mg/5ml | 4A055 | M/s. Rasco Pharma Lahore |
10 | Zonid Suspension 120ml Reg. No. 022579 | Metronidazole 200mg/5ml | Z492 Z246 | M/s. Bloom Pharmaceuticals Hattar |
11 | Butamin Syrup 60ml Reg. No. 016630 | Salbutamol 2mg | 4016 | M/s. P.D.H Pharmaceuticals, Lahore |
12 | Nuocid Plus suspension 120ml Enlst. No. 0327660558 | Zingiber Officinale 20mg/5ml, Mentha Piperita 40mg/5ml | NC-S045 | M/s. Arber Pharma Lahore |
Risk Statement | Di-ethylene Glycol (DEG) and Ethylene Glycol (EG) contaminated oral preparations can lead to serious health risks. When ingested, EG and DEG are converted into toxic metabolites that can affect the central nervous system and heart. Moreover, it can also cause kidney damage which may lead to fatal consequences |
Action Initiated | -The manufacturers of products have been directed to immediately recall the defective batches of from the market. All pharmacists and chemists working at distributions and pharmacies should immediately check their stocks and stop supplying these products. The remaining stocks should be quarantined and returned to the supplier/company. -Distributors and pharmacies are advised to be vigilant and report any suspected batch of the product(s) in the supply chain to the DRAP using the online form, or through phone at +92 51 910 73 17, or by Email at gsms∂dra.gov.pk. -The regulatory field force of all federating units (DRAP, Provincial Health Departments, and States) has also increased the surveillance in the market to ensure the effective recall of defective product(s). |
Advice for Healthcare Professionals | DRAP requests to enhance vigilance within the supply chains of institutions/pharmacies/healthcare facilities likely to be affected by these defective batches of liquid products. -Adverse reactions or quality problems experienced with this product may be reported to the National Pharmacovigilance Centre(NPC), DRAP using the Adverse Event Reporting Form or online through this link. -Please click here for further information on problem reporting to DRAP. |
Advice for Consumers | -Consumers should stop using this product bearing the affected batch number(s). They shall contact their physician or healthcare provider(s) if they have experienced any problem that may be related to using this product. -All therapeutic products must be obtained from authorized licensed pharmacies /outlets. Their authenticity and condition should be carefully checked. If you have any doubts, please seek advice from your pharmacist. |